Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 3/20 | 0.61 |
| ▸ | FAAH | O00519 | 5/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.57 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | SELP | P16109 | 1/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8971354 | 0.98 | CNR1 (0.59) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL3349108 | 0.93 | FAAH (0.70) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL14576902 | 0.92 | CASP2 (0.64) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL16302656 | 0.92 | FAAH (0.63) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL22992630 | 0.91 | CASP2 (0.63) | CASP2CNR1FAAHNAAADNM1 | |
| Hexadecanoic Acid Propylamide SCHEMBL1457463 | 0.91 | FAAH (0.74) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL9964260 | 0.91 | FAAH (0.74) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL5173746 | 0.91 | FAAH (0.74) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL8695820 | 0.91 | FAAH (0.74) | CASP2CNR1FAAHNAAADNM1 | |
| SCHEMBL7760880 | 0.91 | FAAH (0.74) | CASP2CNR1FAAHNAAADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120020119-A | Process for preparing N- (2-substituted ethyl) amides and N-vinyl amides | 中国石油化工股份有限公司 | 2025-05-20 | — | — | CN | claimed |
| US-8143408-B2 | N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | ASTRAZENECA AB (SE) | 2012-03-27 | — | — | US | claimed |
| US-20100137322-A1 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2010-06-03 | — | — | US | claimed |
| EP-2158198-A2 | NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | AstraZeneca AB (SE) | 2010-03-03 | — | — | EP | claimed |
| WO-2008130320-A2 | NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | claimed |
| US-12630731-B2 | Non-aqueous ink composition | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-05-07 | — | — | US | disclosed |
| US-12590216-B2 | Water-based ink and ink set including same | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12522744-B2 | Ink set | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| US-20250368766-A1 | RESIN, RESIN DISPERSION, AND RESIN COMPOSITION | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-12-04 | — | — | US | disclosed |
| EP-4617333-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP Fine Chemicals Co., Ltd. (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-12398444-B2 | Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions | UT-BATTELLE, LLC (US) | 2025-08-26 | — | — | US | disclosed |
| US-4855292-A | ANTIMICROBIAL AGENTS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1989-08-08 | — | — | US | disclosed |
| EP-0308325-A1 | Process for the preparation of di-N-propyl acetonitrile | SANOFI (FR) | 1989-03-22 | — | — | EP | disclosed |
| CN-1030237-A | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1989-01-11 | — | — | CN | disclosed |
| EP-0287951-A2 | 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |
| EP-0267024-A2 | Hydrofluorene derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-05-11 | — | — | EP | disclosed |
| EP-0091519-B1 | TOPICAL ACYLAMINOPHENOLS | Johnson & Johnson Products Inc. (US) | 1987-06-24 | — | — | EP | disclosed |
| EP-0091519-A1 | Topical acylaminophenols | Johnson & Johnson Products Inc. (US) | 1983-10-19 | — | — | EP | disclosed |
| US-4329366-A | ANTIINFLAMMATORY AGENTS | JOHNSON & JOHNSON PRODUCTS, INC. (US) | 1982-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137322-A1 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | OPRL1, OPRK1, OPRD1 | CASP2 1644/4885CNR1 8/4885FAAH 23/4885 |
| US-12630731-B2 | Non-aqueous ink composition | EXOSC10, RPP30, RPS20 | CASP2 4166/4885CNR1 4829/4885FAAH 4881/4885 |
| US-12590216-B2 | Water-based ink and ink set including same | TYR, ITGB3, ARCN1 | CASP2 3784/4885CNR1 4868/4885FAAH 4817/4885 |
| US-12398444-B2 | Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions | GNE, GALE, ARGLU1 | CASP2 4128/4885CNR1 3317/4885FAAH 4539/4885 |
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | BMI1, IK, PRDM9 | CASP2 4563/4885CNR1 4860/4885FAAH 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.